• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    AbbVie’s Parkinson’s drug succeeds in Phase 3 study

    PRESS RELEASE

    AbbVie Announces Topline Results from Ph 3 Trial of Tavapadon

    PR NEWSWIRE

    AbbVie Announces Positive Tavapadon Phase 3 Results for PD

    PR NEWSWIRE

    Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study

    BIOPHARMADIVE

    Cerevel`s Tavapadon Meets Phase 3 Adjunctive Parkinson`s Trial Goals

    GLOBENEWSWIRE

    Cerevel blames Covid for delayed neuroscience studies, says president is leaving

    ENDPTS

    Cerevel Announces First Patients Dosed in all Ph3 Trials of Tavapadon

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.